Gala Global (GLAG) Stock Price, News & Analysis

Company Overview

Gala Pharmaceuticals, Inc. engages in the development, research, and commercialization of products derived from the Hemp and Cannabis Plant. It also provides testing or analytical chemistry tools for chemical, plant, soil, and liquid composition analysis; and provides genetic fingerprinting and sequencing of various crop species. Its services include analytical testing, molecular services, and consulting and training. The company was founded on March 10, 2010 and is headquartered in Irvine, CA.

Key Stats

• Today's Range: $0.26 to $0.26
• 50-Day Range: N/A
• 52-Week Range: $0.20 to $1.50
• Volume: 86 shs
• Average Volume: 4,040 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

GLAG Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Gala Global own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Gala Global investors own include Cannabis Wheaton Income (CBWTF), American Lithium (LIACF), Tapestry (TPR), Lsb Industries (LXU), Refined Metals (CADMF) and Blue Energy (BLU).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Cannabis
• Current Symbol: OTCMKTS:GLAG
• CIK: 1513403
• Web: galapharmaceuticals.com
• Phone: (657) 215-5742
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A